New Pfizer and Merck antivirals look hopeful

With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.

Study reveals what makes the Delta variant so infectious

A part of the SARS-CoV-2 spike protein could prove to be its Achilles’ heel.

Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice

A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.

Third shot of COVID-19 vaccine not justified, says research

An expert review finds that booster shots for the general population are not yet necessary since vaccine efficacy against severe COVID-19 remains high.

Fridge-free COVID-19 vaccine candidates offer hope to billions

Two vaccines in early development are stable under high temperatures and could be game changers in global vaccine equity.

Sign up for our newsletter

Receive the latest science news directly to your inbox once a week

Have a question or feedback?

Contact the Advanced Science News editorial team at advsciencenews@wiley.com.